Mice transgenic for NPM-ALK develop non-hodgkin lymphomas
Background: The t(2;5)(p23;q35) translocation is associated with a high percentage of anaplastic large-cell lymphomas (ALCL) of T- or null-cell phenotype. The translocation produces an 80 kDa hyperphosphorylated chimeric protein (p80) derived from the fusion of the anaplastic lymphoma kinase (ALK) w...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 2005
|
| In: |
Anticancer research
Year: 2005, Jahrgang: 25, Heft: 5, Pages: 3191-3196 |
| ISSN: | 1791-7530 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://ar.iiarjournals.org/content/25/5/3191
|
| Verfasserangaben: | Richard Jäger, Jens Hahne, Andrea Jacob, Angela Egert, Johannes Schenkel, Nicolas Wernert, Hubert Schorle and Axel Wellmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1757121676 | ||
| 003 | DE-627 | ||
| 005 | 20220915130059.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210505s2005 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1757121676 | ||
| 035 | |a (DE-599)KXP1757121676 | ||
| 035 | |a (OCoLC)1341408003 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jäger, Richard |e VerfasserIn |0 (DE-588)1190735970 |0 (DE-627)1669304736 |4 aut | |
| 245 | 1 | 0 | |a Mice transgenic for NPM-ALK develop non-hodgkin lymphomas |c Richard Jäger, Jens Hahne, Andrea Jacob, Angela Egert, Johannes Schenkel, Nicolas Wernert, Hubert Schorle and Axel Wellmann |
| 264 | 1 | |c September 2005 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.05.2021 | ||
| 520 | |a Background: The t(2;5)(p23;q35) translocation is associated with a high percentage of anaplastic large-cell lymphomas (ALCL) of T- or null-cell phenotype. The translocation produces an 80 kDa hyperphosphorylated chimeric protein (p80) derived from the fusion of the anaplastic lymphoma kinase (ALK) with nucleophosmin (NPM). The NPM-ALK chimeric protein is an activated tyrosine kinase that has been shown to be a potent oncogene and presumably plays a causative role in lymphomagenesis. Materials and Methods: A transgenic mouse line was generated, where the human NPM-ALK cDNA is driven by the lck promoter conferring transgene expression to early T-cells. Results: Mice rapidly developed large cell lymphoblastic lymphomas with a median latency of 8 weeks, primarily involving the thymus, with lymph node as well as histologically evident extranodal organ infiltration by large tumor cells. Conclusion: The transgenic approach described provides direct evidence for the strong transforming potential of NPM-ALK in T-cells and furthermore represents a system for the analysis of the oncogenic events mediated by NPM-ALK in vivo, which might be instrumental in the development of tyrosine kinase inhibitor therapies of potential clinical use. | ||
| 650 | 4 | |a ALCL | |
| 650 | 4 | |a lymphoma | |
| 650 | 4 | |a NPM-ALK | |
| 650 | 4 | |a Transgenic mice | |
| 700 | 1 | |a Hahne, Jens Claus |d 1967- |e VerfasserIn |0 (DE-588)122752740 |0 (DE-627)706028759 |0 (DE-576)293407088 |4 aut | |
| 700 | 1 | |a Jacob, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Egert, Angela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schenkel, Johannes |d 1954- |e VerfasserIn |0 (DE-588)115545239 |0 (DE-627)077320107 |0 (DE-576)28994158X |4 aut | |
| 700 | 1 | |a Wernert, Nicolas |e VerfasserIn |0 (DE-588)1268140953 |0 (DE-627)1816726249 |4 aut | |
| 700 | 1 | |a Schorle, Hubert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wellmann, Axel |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anticancer research |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004 |g 25(2005), 5, Seite 3191-3196 |h Online-Ressource |w (DE-627)387478493 |w (DE-600)2145376-7 |w (DE-576)358408717 |x 1791-7530 |7 nnas |a Mice transgenic for NPM-ALK develop non-hodgkin lymphomas |
| 773 | 1 | 8 | |g volume:25 |g year:2005 |g number:5 |g pages:3191-3196 |g extent:6 |a Mice transgenic for NPM-ALK develop non-hodgkin lymphomas |
| 856 | 4 | 0 | |u https://ar.iiarjournals.org/content/25/5/3191 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210505 | ||
| 993 | |a Article | ||
| 994 | |a 2005 | ||
| 998 | |g 115545239 |a Schenkel, Johannes |m 115545239:Schenkel, Johannes |d 50000 |e 50000PS115545239 |k 0/50000/ |p 5 | ||
| 999 | |a KXP-PPN1757121676 |e 3923291442 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 05.05.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1757121676","title":[{"title":"Mice transgenic for NPM-ALK develop non-hodgkin lymphomas","title_sort":"Mice transgenic for NPM-ALK develop non-hodgkin lymphomas"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Jäger, Richard","given":"Richard","family":"Jäger"},{"given":"Jens Claus","family":"Hahne","role":"aut","roleDisplay":"VerfasserIn","display":"Hahne, Jens Claus"},{"given":"Andrea","family":"Jacob","role":"aut","display":"Jacob, Andrea","roleDisplay":"VerfasserIn"},{"family":"Egert","given":"Angela","display":"Egert, Angela","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Schenkel, Johannes","roleDisplay":"VerfasserIn","role":"aut","family":"Schenkel","given":"Johannes"},{"given":"Nicolas","family":"Wernert","role":"aut","roleDisplay":"VerfasserIn","display":"Wernert, Nicolas"},{"family":"Schorle","given":"Hubert","display":"Schorle, Hubert","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Wellmann","given":"Axel","display":"Wellmann, Axel","roleDisplay":"VerfasserIn","role":"aut"}],"physDesc":[{"extent":"6 S."}],"relHost":[{"name":{"displayForm":["International Institute of Anticancer Research"]},"id":{"issn":["1791-7530"],"zdb":["2145376-7"],"eki":["387478493"]},"origin":[{"publisherPlace":"Kapandriti, Attiki, Greece","dateIssuedKey":"2004","publisher":"International Institute of Anticancer Research","dateIssuedDisp":"2004-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"international journal of cancer research and treatment","title":"Anticancer research","title_sort":"Anticancer research"}],"recId":"387478493","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 26.02.13"],"disp":"Mice transgenic for NPM-ALK develop non-hodgkin lymphomasAnticancer research","part":{"pages":"3191-3196","issue":"5","year":"2005","extent":"6","text":"25(2005), 5, Seite 3191-3196","volume":"25"},"pubHistory":["Nachgewiesen 24.2004 -"]}],"origin":[{"dateIssuedDisp":" September 2005","dateIssuedKey":"2005"}],"id":{"eki":["1757121676"]},"name":{"displayForm":["Richard Jäger, Jens Hahne, Andrea Jacob, Angela Egert, Johannes Schenkel, Nicolas Wernert, Hubert Schorle and Axel Wellmann"]}} | ||
| SRT | |a JAEGERRICHMICETRANSG2005 | ||